A significant recent study involving over 20,000 patients has revealed that extremely high levels of an inherited cholesterol-related substance known as Lp(a) notably increase the likelihood of stroke, cardiovascular mortality, and other severe heart-related problems. Approximately one in five individuals exhibit heightened levels of Lp(a), a genetic characteristic unaffected by diet or physical activity unlike typical cholesterol. Researchers, sharing new insights from three prominent NIH-supported investigations, state that this risk is present even in those whose LDL cholesterol is effectively managed through conventional treatment. Given that Lp(a) levels are primarily dictated by genetics, specialists advocate for a straightforward, cost-effective blood test to evaluate levels at any age. If raised Lp(a) is detected, physicians advise patients to take proactive measures to control LDL cholesterol and other cardiovascular risks. Experts highlight that new targeted therapies for elevated Lp(a) are being developed, underscoring the importance of early identification of this risk.
Disclosure:
This video contains stock footage and content created or enhanced using AI-assisted tools.
ai-generated
